PureTech Health Launches $50M Share Buyback Program
Ticker: PTCHF · Form: 6-K · Filed: Mar 4, 2024 · CIK: 1782999
| Field | Detail |
|---|---|
| Company | Puretech Health PLC (PTCHF) |
| Form Type | 6-K |
| Filed Date | Mar 4, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $50 million, $25 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-repurchase, company-announcement
Related Tickers: PRTC
TL;DR
PureTech Health is buying back $50M of its own stock, signaling confidence.
AI Summary
PureTech Health plc announced on May 9, 2022, the initiation of a $50 million share repurchase program. This program allows the company to buy back its own shares, potentially increasing shareholder value.
Why It Matters
A share repurchase program can signal management's confidence in the company's valuation and potentially boost the stock price by reducing the number of outstanding shares.
Risk Assessment
Risk Level: low — This filing is a routine report of a previously announced share repurchase program and does not introduce new material risks.
Key Numbers
- $50 million — Share Repurchase Program (Amount authorized for the company to buy back its shares.)
Key Players & Entities
- PureTech Health plc (company) — Registrant
- $50 million (dollar_amount) — Share repurchase program amount
- May 9, 2022 (date) — Announcement date of share repurchase program
FAQ
What is the purpose of the Form 6-K filing?
The Form 6-K is a report of a foreign private issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of February 2024.
When was the share repurchase program announced?
The share repurchase program was announced on May 9, 2022.
What is the total value of the announced share repurchase program?
The total value of the share repurchase program is $50 million.
What is PureTech Health plc's ticker symbol?
PureTech Health plc's ticker symbols are LSE: PRTC and Nasdaq: PRTC.
Where is PureTech Health plc's principal executive office located?
PureTech Health plc's principal executive office is located at 6 Tide Street, Suite 400, Boston, Massachusetts 02210.
Filing Stats: 719 words · 3 min read · ~2 pages · Grade level 10 · Accepted 2024-03-04 16:51:18
Key Financial Figures
- $50 million — ompany) announced the commencement of a $50 million share repurchase program (the Program)
- $25 million — (excluding expenses) of no greater than $25 million and the simultaneous on-sale of such Or
Filing Documents
- d762504d6k.htm (6-K) — 18KB
- 0001193125-24-057956.txt ( ) — 19KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PURETECH HEALTH PLC Date: March 4, 2024 By: /s/ Daphne Zohar Name: Daphne Zohar Title: Chief Executive Officer